Show
Sort by
-
Genetic and microbial factors modulating the ubiquitin proteasome system in inflammatory bowel disease
-
Analysis of HER2 expression and gene amplification in adenocarcinoma of the stomach and the gastro-oesophageal junction : rationale for the Belgian way of working
-
Prognostic value of serologic and histologic markers on clinical relapse in ulcerative colitis patients with mucosal healing
-
Effects of haptoglobin polymorphisms and deficiency on susceptibility to inflammatory bowel disease and on severity of murine colitis
-
FISH analysis of Lactobacillus biofilms in the gastrointestinal tract of different hosts
-
Mucosal gene expression profiling differentiates early from late ileal Crohn's disease
-
Mucosal gene expression of cell adhesion molecules, chemokines, and chemokine receptors in patients with inflammatory bowel disease before and after infliximab treatment
-
Emphasis on the key role of the pathologist in KRAS mutation testing in the selection of patients for EGFR-targeted therapy in colorectal cancer
-
Accurate KRAS mutation testing for EGFR-targeted therapy in colorectal cancer : emphasis on the key role and responsibility of pathologists
-
Pathologische beoordeling van het resectiepreparaat bij rectumkanker